medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2012, Número 4

<< Anterior Siguiente >>

Ann Hepatol 2012; 11 (4)


The socioeconomic impact of hepatitis C infection and liver transplantation in Mexico

Méndez-Sánchez N

Idioma: Ingles.
Referencias bibliográficas: 13
Paginas: 550-551
Archivo PDF: 55.66 Kb.


FRAGMENTO

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17: 107-15.

  2. Valdespino JL, Conde-González CJ, Olaiz-Fernández G, et al. Seroprevalencia de la hepatitis C en adultos de México: ¿un problema de salud pública emergente? Sal Pub Mex 2007; 49: 395-403.

  3. Méndez-Sánchez N, Gutiérrez-Grobe Y, Kobashi-Margáin RA. Epidemiology of HCV infection in Latin America. Ann Hepatol 2010; 9(Suppl.): 27-9.

  4. Censo de Población y Vivienda de México 2010. Available from: www.inegi.org.mx

  5. Keeffe EB. Liver transplantation: current status and novel approaches to liver replacement. Gastroenterology 2001; 120: 749-62.

  6. Thomas DL. Advances in the treatment of hepatitis C virus infection. Top Antivir Med 2012; 20: 5-10.

  7. Poordad F, McCone J Jr., Bacon BR, et al. Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med 2011; 364: 1195-206.

  8. Jacobson IM, McHutchinson, JG, Dusheiko G, et al. Teleprevir in combination with Peginterferon and Ribavirin in treatment-naïve patients with genotype 1 chronic hepatitis C. N Engl J Med 2011; 364: 2405-16.

  9. Bacon BR, Gordon SC, Lawitz E, et al. Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med 2011; 364: 1207-17.

  10. Bruno S, Silini E, Crosignani A, Borzio F, Leandro G, Bono F, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 1997; 25: 754-8.

  11. Lee CM, Lu SN, Hung CH, Tung WC, Wang JH, Tung HD, et al. Hepatitis C virus genotypes in southern Taiwan: prevalence and clinical implications. Trans R Soc Trop Med Hyg 2006; 100: 767-74.

  12. U.S. & World Population Clocks. http://www.census.gov/ main/www/popclock.html. [Accessed April 17,2012].

  13. Cammà C, Petta S, Enea M, Bruno R, Bronte F, Capursi V, Cicchetti A, Colombo GL, et al; on behalf of the WEF Study Group. Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C. Hepatology 2012. Doi: 10.1002/hep.25734 [Epub ahead of print].




2020     |     www.medigraphic.com